0001446472-24-000002.txt : 20240426
0001446472-24-000002.hdr.sgml : 20240426
20240425180438
ACCESSION NUMBER: 0001446472-24-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240426
DATE AS OF CHANGE: 20240425
EFFECTIVENESS DATE: 20240426
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-PATH HOLDINGS, INC.
CENTRAL INDEX KEY: 0001133818
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 870652870
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-511650
FILM NUMBER: 24877939
BUSINESS ADDRESS:
STREET 1: 4710 BELLAIRE BOULEVARD
STREET 2: SUITE 210
CITY: BELLAIRE
STATE: TX
ZIP: 77401
BUSINESS PHONE: (832) 742-1357
MAIL ADDRESS:
STREET 1: 4710 BELLAIRE BOULEVARD
STREET 2: SUITE 210
CITY: BELLAIRE
STATE: TX
ZIP: 77401
FORMER COMPANY:
FORMER CONFORMED NAME: BIO-PATH HOLDINGS INC
DATE OF NAME CHANGE: 20080221
FORMER COMPANY:
FORMER CONFORMED NAME: OGDEN GOLF CO CORP
DATE OF NAME CHANGE: 20010205
D
1
primary_doc.xml
X0708
D
LIVE
0001133818
BIO-PATH HOLDINGS, INC.
4710 BELLAIRE BOULEVARD
SUITE 210
BELLAIRE
TX
TEXAS
77401
(832) 742-1357
DELAWARE
BIO-PATH HOLDINGS INC
OGDEN GOLF CO CORP
Corporation
true
Peter
H.
Nielsen
4710 Bellaire Boulevard
Suite 210
Bellaire
TX
TEXAS
77401
Executive Officer
Director
Heath
W.
Cleaver
4710 Bellaire Boulevard
Suite 210
Bellaire
TX
TEXAS
77401
Director
Paul
D.
Aubert
4710 Bellaire Boulevard
Suite 210
Bellaire
TX
TEXAS
77401
Director
Douglas
P.
Morris
4710 Bellaire Boulevard
Suite 210
Bellaire
TX
TEXAS
77401
Director
Aline
Sherwood
4710 Bellaire Boulevard
Suite 210
Bellaire
TX
TEXAS
77401
Director
Biotechnology
Decline to Disclose
- 06b
false
2024-04-18
false
true
true
false
0
H.C. Wainwright & Co., LLC
375
None
None
430 Park Avenue
New York
NY
NEW YORK
10022
All States
false
1275880
1275880
0
Includes warrants to purchase up to 375,000 shares of common stock and warrants to purchase up to 28,125 shares of common stock issued to H.C. Wainwright & Co., LLC ("HCW Warrants"), with an exercise price of $3.10 and $4.0313, respectively.
false
3
102796
0
H.C. Wainwright & Co., LLC received the above sales commission and the HCW
Warrants as consideration, in connection with a registered direct offering by the Issuer, which is not reported on this Form D.
0
true
false
BIO-PATH HOLDINGS, INC.
/s/ Peter H. Nielsen
Peter H. Nielsen
President and Chief Executive Officer
2024-04-25